TVARDI THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
TVARDI THERAPEUTICS, INC. (TVRD) reported Earnings Per Share, Basic and Diluted of -$0.02 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-08
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.02.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.61.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.47.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.35.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.49.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.06.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.86.
- TVARDI THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$2.10.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$0.02 10-Q · filed 2021-11-08 | -$1.10 10-Q · filed 2021-11-08 | ||
| 2021-06-30 | -$0.61 10-Q · filed 2021-08-09 | -$1.08 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | -$0.47 10-Q · filed 2021-05-10 | |||
| 2020-09-30 | -$0.35 10-Q · filed 2021-11-08 | -$1.51 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$0.54 10-Q · filed 2021-08-09 | -$1.15 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$0.62 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | -$0.61 10-K · filed 2021-02-25 | -$2.49 10-K · filed 2020-02-27 | ||
| 2019-09-30 | -$0.74 10-K · filed 2021-02-25 | -$1.88 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$0.58 10-K · filed 2021-02-25 | -$1.13 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$0.56 10-K · filed 2021-02-25 | |||
| 2018-12-31 | -$0.52 10-K · filed 2020-02-27 | -$2.06 10-K · filed 2020-02-27 | ||
| 2018-09-30 | -$0.51 10-K · filed 2020-02-27 | -$1.54 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$0.52 10-K · filed 2020-02-27 | -$1.03 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$0.51 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$0.43 10-K · filed 2019-03-12 | -$1.86 10-K · filed 2020-02-27 | ||
| 2017-09-30 | -$0.38 10-K · filed 2019-03-12 | -$1.43 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$0.29 10-K · filed 2019-03-12 | -$1.06 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$0.81 10-K · filed 2019-03-12 | |||
| 2016-12-31 | -$0.81 10-K · filed 2018-03-15 | -$2.10 10-K · filed 2019-03-12 | ||
| 2016-09-30 | -$0.42 10-K · filed 2018-03-15 | -$1.29 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$0.48 10-K · filed 2018-03-15 | -$0.87 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | -$0.39 10-K · filed 2018-03-15 | |||
| 2015-12-31 | -$0.35 10-K · filed 2017-03-10 | -$1.00 10-K · filed 2018-03-15 | ||
| 2015-09-30 | -$0.19 10-K · filed 2017-03-10 | -$0.64 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | -$0.25 10-K · filed 2017-03-10 | -$0.45 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$0.21 10-K · filed 2017-03-10 | |||
| 2014-12-31 | -$0.18 10-K · filed 2016-03-11 | -$0.85 10-K · filed 2017-03-10 | ||
| 2014-09-30 | -$0.29 10-K · filed 2016-03-11 | -$0.67 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | -$0.16 10-K · filed 2016-03-11 | -$0.37 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | -$0.22 10-K · filed 2016-03-11 | |||
| 2013-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$1.55 derived: net income ÷ weighted average shares · filed 2016-03-11 | -$0.74 10-K · filed 2016-03-11 | |
| 2013-09-30 | -$1.07 derived: net income ÷ weighted average shares · filed 2015-03-27 | -$1.19 derived: net income ÷ weighted average shares · filed 2015-03-27 | ||
| 2013-03-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |